FGF19 and Hepatitis: Clinical trials have been performed or are recruiting to test the application of FMT, drugs (eg, anti-alcoholism drug disulfiram), diets, probiotics, synbiotics, antibiotics, fibroblast growth factor 19 analog (aldafermin or NGM282), and physical activity for the treatment of liver inflammation and gut microbiota dysbiosis.